The building of the vessel wall from its cellular and extracellular matrix (ECM) components is a critical event in the development and maturation of the cardiovascular system. However, little is known about the events that occur after the initial vascular network, a nascent endothelium, is established. The proper recruitment of vascular smooth muscle cells (VSMCs) to the endothelium is one such critical event. Although the majority of VSMCs are of mesodermal origin, it is not understood which populations of embryonic cells are capable of following the VSMC differentiation pathway. Previous studies, which have focused on the VSMC component of vessel wall development, have been limited by the use of markers that are not smooth muscle specific, or have focused on events that occur after a multilayered wall has been established. Therefore, the initial goal of this study was to define when overtly identifiable VSMCs were first associated with the vascular endothelium. Monoclonal antibodies (MAbs) were generated from embryonic vessel wall antigens in order to circumvent problems of cell specificity associated with the use of previously available markers to VSMCs. Critical to this study is our MAb, 1E12, which unlike other antibody markers, is smooth muscle specific. Using 1E12, we defined a pattern for recruitment and differentiation of the VSMC component of the descending aorta in stage 12 to stage 20 (Hamburger and Hamilton, 1951) quail embryos. Immunofluorescent labeling of quail embryos with 1E12 and a MAb to smooth muscle a-actin (SMaA) shows that the first mesodermally derived cells to associate with the aortic endothelium do so at the ventral surface. Recruitment of these cells, which we believe to be primordial VSMCs, proceeds in a ventral to dorsal direction along the aorta and in a radial direction, emanating from the endothelium. Additionally, we have determined the distribution of several ECM proteins, during the initial events of vessel wall development. Our studies show that fibulin-1 is expressed surrounding the primordial VSMCs of the vessel wall before elastin precursors are present and suggest that differential expression of the JB3 antigen (Wunsch et al., 1994) may be indicative of early diversity among embryonic VSMCs. ᭧
INTRODUCTION
1991; and for a recent review of the VSMC see Schwartz and Mecham, 1995) . Although it is clear that VSMCs are The formation and maintenance of the vascular system integral to understanding vascular development and homeois essential for vertebrate development, maturation, and hostasis, little is known about the recruitment of VSMC promeostasis. The process begins with the formation of nascent genitors and the subsequent differentiation program these endothelial tubes by means of vasculogenesis and/or angiocells undergo. The majority of VSMCs are of mesodermal genesis (Coffin and Poole, 1988; Poole and Coffin, 1989;  origin, but unlike other mesodermal precursor cell popula- Pardanaud et al., 1989) . The next event during vascular detions (including skeletal and cardiac muscle cells), a discrete velopment is the proper recruitment of vascular smooth population of VSM progenitor cells cannot be distinguished muscle cells (VSMCs) to the nascent endothelium. Both in the developing organism. (A subpopulation of neural crest the synthetic and contractile functions of the embryonic cells contributes to the smooth muscle layers of the outflow VSMCs are critical for the establishment of a physiologitract and aortic arches, as well as portions of the heart.) (See Le Lievre and Le Douarin, 1975; and Kirby and cally mature vessel (Berne and Levy, 1988; Mecham et al., Waldo, 1995 , for discussion of neural crest derived VSMCs.) located on either side of the midline, in a cranial to caudal direction as development proceeds, which makes this an Thus, it is not understood whether there are mesodermal subpopulations destined to become VSMCs or whether loideal system for studying the vessel wall, as several distinct developmental events can be observed within a single emcal epigenic factors bias competent cells toward a vascular smooth muscle lineage.
bryo. A series of monoclonal antibodies (MAbs) to embryonic Central to studying VSMC determination and differentiation is understanding the coordinated temporal expresvessel wall antigens was constructed, based on the hypothesis that mesodermal precursor cells express novel proteins sion and regulation of VSMC genes . A critical question is to determine when, during vessel wall foras they become committed to the VSMC lineage and that MAbs would be a method of identifying such markers. One mation, VSMCs are first recruited to nascent endothelial tubes and become overtly identifiable as VSMCs, based on of these MAbs, 1E12, was critical to the present study of vessel wall development. The 1E12 MAb labels smooth expression of marker proteins. The two major limitations for answering this question have been: (1) most of the muscle in both embryonic and adult tissues, including visceral organs. We have used 1E12 in conjunction with a MAb markers studied are not smooth muscle specific and (2) previous studies have focused on relatively late developto SMaA to define the cellular and morphological pattern of VSMC recruitment and differentiation. mental stages, after a multilayered vessel wall already has been established. The most commonly used marker for
We have also examined the distribution of several ECM proteins during the initial events of vessel wall developVSMCs is smooth muscle a-actin (SMaA) (Gabbiani et al., 1981; Fatigati and Murphy, 1984; Owens and Thompson, ment, because regulation of expression of ECM proteins by developing VSMCs is often overlooked in relation to other 1986). Unfortunately SMaA is expressed in multiple embryonic cell types, including cardiac and skeletal myo-VSMC proteins. Recently, ECM microfibrillar and microfibrillar associated proteins (for example fibrillin, fibulin 1 blasts, as well as primordial smooth muscle cells (Skalli et al., 1986; Glukhova et al., 1988; Ruzicka and Schwartz, and 2, and the JB3 antigen, a putative avian fibrillin) have been implicated in development of the cardiovascular sys-1988; Sawtell and Lessard, 1989; de Ruiter et al., 1990; Sugi and Lough, 1992) . Therefore, SMaA expression alone tem (Spence et al., 1992; Zhang et al., 1993; Gallagher et al., 1993; Wunsch et al., 1994; Zhang et al., 1994 Zhang et al., , 1996 ; is not diagnostic for identification of primordial VSMCs. A recent report by Duband and co-workers (1993) suggests Bouchey et al., 1996) . Although the function of these proteins during development is not well understood, our studthe use of the smooth muscle proteins calponin and SM22 as ''differentiation markers'' for smooth muscle. However, ies suggest that expression of fibulin-1 may be an early marker for differentiating VSMCs, while the expression patthese markers appear relatively late in the course of vessel wall development (avian Embryonic Day 4 and Day 6 for tern of the JB3 antigen may be indicative of the diversity within the VSMC developmental program. SM22 and calponin, respectively); also, both calponin and SM22, like SMaA, are expressed in non-smooth muscle cells during development (Li et al., 1996; Samaha et al., 1996; Miano and Olson, 1996) . have
MATERIALS AND METHODS
shown by in situ hybridization and RNase protection studies that expression of the smooth muscle myosin heavy Hybridoma Production chain (MHC) isoforms, MHC-1 and MHC-2, is restricted to Four 6-to 8-week-old female Balb-c mice were immunized subcusmooth muscle cells at 10.5 days postcoitum in embryonic taneously with a crude homogenate of 10-day-old embryonic quail mice. Although MHC transcripts are the first reported tisdorsal aorta (two aortae per mouse per injection) in Freund's comsue specific markers for smooth muscle cells, they also are plete adjuvant (Sigma) and boosted twice at 14-day intervals with expressed after the initial, critical stages of vessel wall homogenized aortae (same as above) in Freund's incomplete adjuformation have occurred. In addition to the lack of approvant (Sigma). Ten days after the last injection, tailbleeds were perpriate markers, the fact that a number of different organformed, and the serum activity was assessed via immunofluoresisms and in vitro experimental systems have been utilized cence microscopy of 5-day-old embryonic quail cross sections. Mice to study VSMCs makes a comprehensive understanding of producing antibodies directed against the embryonic quail vasculature were chosen as spleen donors for fusion with myeloma cells. smooth muscle differentiation difficult. For example, there A total of four lymphocyte-myeloma fusions were performed.
are no available data on the specificity of MHC expression Fusions were performed in the standard manner by the Univerduring avian development. sity of Virginia Lymphocyte Culture Center (Chapman et al., 1984) .
In contrast, the present study focuses on the events of The only modification to this protocol being that the base media vessel wall development that take place immediately after in which the hybridomas were prepared and maintained was Iscov's the establishment of a nascent endothelial vascular netmodified DMEM (Gibco-BRL) supplemented with 10% fetal bovine work. As a model system for studying vessel wall formation, serum (Hyclone; Ogden, UT), 0.06 mM b-mercatoethanol, and 50
we have used the descending aorta of early staged quail mg/liter gentamicin. Cultures were subsequently maintained in embryos (Day 2-3). This period was chosen because it is our laboratory and screened 10-15 days postfusion. Wells producan active period of vessel wall morphogenesis. The avian ing hybridomas were screened by immunofluorescence microscopy of 5-day-old embryonic quail cross sections. Positive hybridomas aorta forms from the fusion of two vessels (dorsal aortae), Copyright ᭧ 1996 by Academic Press, Inc. All rights of reproduction in any form reserved. were determined to be those which showed specific labeling of the For double immunofluorescent labeling of 1E12 and SMaA, cleared sections were incubated simultaneously with both primary embryonic vasculature. Positive hybridoma cultures were cloned at least twice and also screened by immunofluorescence of 5-dayantibodies. 
and PEGD Sectioning
Japanese quail embryos were collected and staged by the criteria of Hamburger and Hamilton (1951) . Embryos were then fixed in
Immunological Reagents
either Omnifix (Zymed Labs, San Francisco, CA) or methacarn SMaA monoclonal antibodies were obtained from Sigma (clone (60% methanol, 10% glacial acetic acid, and 30% chloroform) for 1A4, Skalli, 1986) and used diluted (1:200 or 1:400) with PBS. A 1-2 hr (Omnifix) or overnight (methacarn). Embryos were subsepolyclonal antibody to human fibulin-1 was produced in rabbits quently dehydrated through a graded series of either ethanol (Omand used at a 1:50 dilution. The monoclonal antibody to the JB3 nifix fixation) or methanol (methacarn fixation). Fixed, dehydrated antigen was obtained from Drs. Ann Wunsch (Medical College of embryos were embedded in either polyethylene glycol 400 distearWisconsin; Milwaukee, WI) and Roger Markwald (Medical Univerate (PEGD, Aldrich Chemicals) or paraffin.
sity of South Carolina; Charleston, SC). JB3 hybridoma supernatant Embryos were prepared for embedding in PEGD by modifications was used undiluted. The QH1 MAb was obtained from the Developof the methods of Steedman (1957) and Spence et al. (1992) . The mental Studies Hybridoma Bank (University of Iowa, Iowa City, infiltration process was initiated by incubating the dehydrated em-IA). QH1 hybridoma supernatant was also used undiluted. Both the bryos in a 1:1 solution of absolute ethanol and 100% melted PEGD 1E12 and 9D6 MAbs were used as undiluted hybridoma supernain a 43ЊC oven. Embryos were further infiltrated in two changes tants. All secondary antibodies were purchased from Jackson Imof 100% melted PEGD at 43ЊC. After infiltration, embryos were munoresearch (West Grove, PA) and used at a 15 mg/ml dilution. oriented in embedding molds (Baxter) filled with fresh 100% melted PEGD and allowed to harden at room temperature (RT).
Fixed, dehydrated embryos were prepared for paraffin embedding
Immunofluorescence Controls
by incubation at RT in 100% xylene for 1 hr. Embryos were then infiltrated by incubation through a series of xylene:paraffin (3:1, Appropriate controls were used for all of the immunolabeling 1:1, 1:3) solutions and two final incubations in 100% paraffin. All studies presented in this work. Preimmune (when available) or nonof the above steps were approximately 6 hr in length and were immune sera were used as negative controls for the primary anticarried out in a 58ЊC oven. Embryos were then oriented in embedbody. For the hybridomas that we produced, nonimmunoreactive ding molds (Baxter) filled with fresh 100% melted paraffin.
hybridoma supernatant was used as a control. All secondary antiEmbryos embedded in either PEGD or paraffin were sectioned bodies were controlled by labeling of tissue sections. When a single on a Spencer (American Optical Co.) microtome set at 7 mm. For fluorochrome was utilized for immunolabeling, the fluorescent sig-PEGD sections, ribbons were placed on clean, poly-L-lysine (Sigma, nal was evaluated for crossover into other wavelengths. St. Louis, MO)-coated slides. Distilled water was then pipetted underneath the sections to allow for flattening and spreading. Slides were placed on a warmer set at 37ЊC for 5 min and allowed to dry Imaging at room temperature overnight. For paraffin sections, ribbons were floated on warm water and mounted on clean, uncoated slides.
One image (Fig. 1a) was created using digital image processing Slides were allowed to dry for approximately 45 min on a warmer software. A standard photographic negative was converted to a digiset at 40ЊC.
tal image file using a flatbed scanner (UMAX Power Look). The file was then imported into an image editing software program (Adobe Photoshop) and processed using contrast enhancement and
Immunolabeling of PEGD and Paraffin
sharpening filters. The resulting high-contrast image (including specific immunofluorescence and background autofluorescence)
Tissue Sections
was rendered as a three-dimensional relief object. Slides containing PEGD sections were cleared in multiple washes of warm absolute ethanol and rehydrated in phosphate-buffered saline (PBS). Slides containing paraffin sections were cleared in Immunoblot several washes of 100% xylene, followed by rehydration in a graded series of ethanol, and a final incubation in PBS. All sections were Chicken gizzards were homogenized in Tris-buffered saline (0.05 M Tris/HCl, pH 7.5, 0.15 M NaCl) and cleared by centrifugation then blocked in a solution of 3% bovine serum albumin (BSA) in PBS for 30 min. Immunolabeling of all sections was accomplished as described (Hungerford, 1995; manuscript in preparation) . Aliquots of the supernatant were mixed with SDS-PAGE sample in the following manner: sections were incubated in primary antibodies for 1 hr, washed in three changes of PBS, followed by incubabuffer (Laemmli, 1970) and subjected to electrophoresis on 10% polyacrylamide gels. The fractionated polypeptides were transtion in secondary antibodies for 1 hr, and additional washing in PBS. All sections were then mounted in GelMount (Biomeda, Foster ferred to nitrocellulose membranes (Towbin et al., 1979) , blocked with nonfat milk/PBS, and then incubated with 1E12 antibodies (1 City, CA) and viewed on a Leitz DMR photomicroscope using DICFluotar objectives. hr). It was necessary to incubate the 1E12 IgM in a solution of 0.5% SDS for 1 hr at room temperature prior to incubation with the that while SMaA is known to be expressed by primordial membrane. After washing in PBS the membrane was incubated cardiac muscle cells (Sugi and Lough, 1992 ; Ruzicka and with chemiluminescence reagents (ECL blotting kit, Amersham Schwartz, 1988) , the 1E12 antigen was never observed in Life Sciences) and exposed to X-ray film.
the developing cardiac muscle (Hungerford, 1995) . During later development, 1E12 is localized in all other smooth muscle structures (including the vessel wall of both the
RESULTS
arterial and venous circulations, as well as all visceral smooth muscle containing tissues); however, during this period of development, vascular tissue is the only smooth Production of the 1E12 MAb muscle containing structure in the embryo. It appears from To develop MAbs that could be used to identify VSMCs our data that at these early stages, development of the aortic at early stages of vascular development, we immunized wall preceeds that of the cardinal veins, such that 1E12 will mice with crude extracts of embryonic quail vessel wall be expressed by venous smooth muscle cells at later stages tissue (see Materials and Methods). All of the immunized (data not shown). Therefore, 1E12 defines a cell type mice exhibited robust immunological responses to the emuniquely associated with endothelium at these early develbryonic quail vascular antigens, as demonstrated by screenopmental stages. ing of the post immune sera. Immune sera were immunoreactive with vascular cells of both small and large vessels, including the descending aorta, and ECM surrounding vas- To determine precisely the time and place presumptive Hamburger and Hamilton, 1951) quail embryo at the level VSMCs become associated with the nascent endothelium, of the heart atrium, immunolabeled with 1E12. Figure 1a we analyzed serial cross sections of stage 12 to stage 20 is a digitally created 3D relief image of the epifluorescence quail embryos using differential interference contrast (DIC) view shown in Fig. 1b 
Mesodermally Derived Presumptive VSMCs

Recruitment to the Aortic Endothelium
observed in any other intraembryonic mesodermal structures, although several extraembryonic mesodermal cells In order to determine whether the cells that we first obare labeled (arrowhead, Fig. 5c ). serve associating with the endothelium express SMaA and
The cross section in Fig. 6a is also immunostained with the 1E12 antigen, progressively older embryonic stages were the SMaA MAb. In this region of a stage 15 (Ç2.25-day) examined with immunofluorescence microscopy, beginembryo the dorsal aortae are located at the midline and the ning at stage 12. The first cells to express SMaA in the endoderm has formed the primitive gut. The majority of vicinity of the descending aorta are located adjacent to the SMaA-positive cells are located adjacent to the endotheendothelium on the ventral surface of stage 12/ (17-somite lium, particularly on the ventral surface (arrowheads, Fig.  or Ç2-day embryo) dorsal aortae, which are in the process 6a). Interestingly, immunoreactivity was also observed of fusing at the midline (Fig. 5a) . In comparison to a serial within cells situated between the fusing endothelial tubes section immunolabeled with the QH1 MAb (Fig. 5b) , a reli-(arrow, Fig. 6a ). Endothelial cells were not labeled with the able marker for the endothelial cell lineage (Pardanaud et al., 1987; Coffin and Poole, 1988) , it is apparent that the SMaA MAb, as shown in a high-magnification view of SMaA immunofluorescence superimposed on a DIC image Expression of the 1E12 antigen is first observed at stage 17-18, approximately 8-12 hr after the onset of SMaA ex- (Fig. 6b) . In contrast to the SMaA MAb, 1E12 did not label the presumptive primordial VSMCs surrounding the endopression. Figures 7a and 7b show low-and high-magnification cross-sectional views through a stage 18 embryo in a thelium of unfused aortae at these developmental stages (data not shown).
region where the individual dorsal aortae have completely fused. A layer of mesodermally derived cells immediately As the vessel wall matures, several distinct layers of cells form, at which time the labeling pattern for the SMaA MAb adjacent to the aortic endothelium stain with 1E12. On the ventral surface of the vessel 1E12-positive cells are present becomes more complex. In the caudal region of a stage 19 quail embryo (Fig. 6c ) SMaA expression is detected in the in several layers of the mesoderm surrounding the endothelium (Fig. 7a) . A few of these cells appear to be labeled on cells most adjacent to the endothelium; however, an additional group of SMaA-positive cells are observed ventral to their entire periphery (arrowhead, Fig. 7b ). On the lateral aspect of the vessel 1E12 labeling is observed only in the the fusing aortae in the midline (arrows). SMaA labeling of a stage 20 cross section (Fig. 4b) localizes to the layers closlayer of mesodermal cells adjacent to the endothelium. At a higher magnification the 1E12 labeling appears to be disest to the endothelium, corresponding to the condensation of cells designated by the arrowheads in Fig. 4a . In addition tributed as a thin line of fluorescence at the periphery of the cells, particularly where they appose the basal surface SMaA is expressed in a group of cells located ventral to the aorta (arrow, Fig. 4b ) which are not associated with the of the endothelium (arrow, Fig. 7b ). Double immunolabeling of similarly staged embryos with 1E12 and the QH1 multilayered vessel wall. MAb clearly shows that 1E12 does not label the vascular in the avian embryo, we examined the expression of the 1E12 antigen at multiple morphogenic stages within indiendothelium (data not shown).
As vessel wall development proceeds, the expression of vidual quail embryos. Figure 8 shows a representative series of cross-sectional views through the descending aorta of a the 1E12 antigen recapitulates the cranial to caudal and ventral to dorsal expression pattern that was observed with stage 20 embryo. Figure 8a is the most caudal section of this series, where the individual aortae are newly fused. SMaA expression. The 1E12 expression pattern also recapitulates the radial pattern of SMaA expression, emanating 1E12 is expressed in only a small population of cells most adjacent to the ventral aortic endothelium (arrowheads). In from the cells that are closest to the endothelium. By exploiting the progression of cranial to caudal developmental progressively cranial sections, Figs. 8b-8d, an increasing number of 1E12-positive cells are detected in the mesoderdorsal surface of the aorta and culminates at the ventral surface. As previously shown in Fig. 2 , at this stage of develmally derived cells surrounding the ventral surface of the aorta (arrowheads). In Fig. 8d , the most cranial, and hence opment (stage 20) the cells that express both the 1E12 antigen and SMaA are a subset of the total population of SMaAmost mature, of this series, 1E12-positive cells, are present as a thin layer over the dorsal surface of the aorta (arrow).
positive cells. Furthermore, this subset is composed of those cells located closest to the endothelial basement mem- Figure 8d also depicts the fact that there is a progressive increase in 1E12 immunoreactive cells, which begins at the brane.
The 1E12 Antigen
All embryonic and adult chicken smooth muscle tissues examined were cross-reactive with 1E12, while rat smooth muscle tissue was not (data not shown). The 1E12 MAb was determined to be of the IgM isotype, a pentameric immunoglobulin; hence, standard approaches for establishing an apparent molecular weight of the antigen have been unsuccessful. However, by treating the IgM with SDS prior to immunoblotting, we identified a band (M r Å 100,000) from extracts of adult chicken gizzard that is reproducibly recognized by the 1E12 MAb (arrowhead; Fig. 11) . We also observe a doublet of variably reactive bands at approximately 40 kDa on the SDS-PAGE gels. In some preparations the lower band of the doublet is stronger than the upper band; in other instances the doublet is faint (not shown). The crisp band at 100 kDa is, however, readily detectable. Due to the variability of the doublet, we are now in the process of generating a recombinant single-chain antibody, which we hope will be more suitable for characterization of the 1E12 antigen.
ECM Expression in the Developing Vessel Wall
In addition to cytoskeletal markers, the distribution of several ECM proteins, fibulin-1, the JB3 antigen, and fibronectin (FN), were compared in order to understand better the role of ECM proteins during smooth muscle maturation. Fibulin-1 is first expressed in the unfused aortae from a caudal region of a stage 19 embryo, a time when SMaApositive cells are observed only on the ventral surface of these vessels (arrow, Fig. 9a ). At this very early stage of vessel wall development, fibulin-1 expression also forms as a thin layer surrounding cells on the ventral surface of the aortae (arrows, Figs. 9b). Immunostaining is also detected surrounding the notochord (x, Fig. 9b ). This notocord-associated staining should not to be confused with the blood vessel-associated antigen. A cross section from an adjacent region of the stage 19 embryo was immunolabeled with a Fig. 9c) . Instead, the JB3 antigen seems to be ex- We also compared fibulin-1 and JB3 distribution in the onstrate an interesting phenomenon. As shown in Fig. 10 , the expression pattern for the JB3 antigen varies between developing vessel wall to that of a putative fibronectin (FN) variant (Fig. 9d) . The 9D6 MAb used in this comparison large and small vessels. Immunolabeling of JB3 (Fig. 10a ) was compared to that of 1E12 (Fig. 10b ) in adjacent sections was also produced by screening of hybridomas generated from embryonic vessel wall antigens (see Materials and of the descending aorta. It appears that the presumptive VSMCs closest to the endothelium, which are 1E12 posiMethods). Although a comprehensive characterization of the 9D6 antigen has not been completed, the 9D6 antigen tive, are not associated with the JB3 antigen. In contrast, smaller peripheral vessels in the body wall of this embryo comigrates with chicken plasma FN on SDS-PAGE and is recognized by a polyclonal antibody to chicken plasma FN demonstrate a contrasting distribution pattern for these molecules. In these vessels the JB3 antigen is associated by immunoblotting techniques (Hungerford, 1995 , and data not shown). Fibronectins are widely distributed in the emwith the endothelium, or the cells most adjacent to the endothelium (arrows, Fig. 10c) , at a time when the 1E12 bryo at these early developmental stages; however, 9D6 appears to preferentially label the ECM surrounding develantigen is not expressed in these vessels (Fig. 10d ). oping vessels (Hungerford, 1995) . As shown in Fig. 9d , the 9D6 antigen is distributed in the ECM surrounding all aspects of the fusing aortae. This image also shows that 9D6
DISCUSSION
is differentially expressed at this stage of development, with expression decreasing in a ventral to dorsal direction.
The establishment of the vessel wall requires the proper spacial and temporal organization of cellular and connective Expression of the JB3 antigen was not observed in a ventral to dorsal pattern around the fusing developing descendtissue components. While recent research in the field of vascular biology has focused on the initial formation and ing aorta. However, cross sections of stage 22 embryos dem-regulation of nascent endothelial tubes, there is little information regarding the subsequent steps of VSMC recruitment and differentiation. Numerous studies in many different experimental systems have attempted to define the program required for VSMC differentiation (reviewed by . The ability of a given VSMC to exist along a continuum of phenotypes has made the regulatory mechanisms of VSMC development and differentiation difficult to study (Thyberg et al., 1990; . Several recent reports demonstrate new approaches to understanding the regulation of smooth muscle differentiation. These include the use of a retinoic acid-induced clonal cell line that expresses smooth muscle characteristics (Rudnicki et al., 1990; Blank et al., 1995) and the generation of a loss-offunction mutation in the Drosophila D-mef2 transcription factor, which results in embryos that are able to properly specify and position myoblasts, but do not have differentiated skeletal, cardiac, or visceral smooth muscles (Lilly et al., 1995) . However, fundamental questions regarding the developmental pathway of VSMCs during the initial events of commitment and subsequent integration into the vessel wall remain unanswered.
Our data provide evidence that the initial population of primordial VSMCs to associate with the endothelium of the dorsal aortae do so at the ventral surface of the fusing vessel by stage 12/. Using a novel smooth muscle-specific MAb, 1E12, a MAb to SMaA, and a polyclonal antibody to fibulin-1, we have defined a pattern of VSMC development around the descending aorta. Embryonic VSMCs develop in both a ventral to dorsal manner, as well as in a radial pattern emanating from the layer of cells most adjacent to the endothelium. This model is supported by the observations of other groups (de Ruiter et al., 1990; Sugi and Lough, 1992; Duband et al., 1993) . While the work of Burke et al. (1994) describes the ontogeny of vessel wall components of the outflow tract in more advanced developmental stages, this study is, to date, the first detailed description of a vessel (the descending aorta) beginning at the stage of a nascent endothelial tube and ending after a multilayered vessel wall is established. cent area of the embryo is localized to the ECM surrounding cellson the ventral surface of the aortae (arrows). Additional labeling is seen around the notochord (x). Fibulin-1 is not ubiquitously expressed in the mesoderm. (c) Unlike fibulin-1 expression, the JB3 antigen is not localized around cells on the ventral surface of the fusing aortae  FIG. 9 . Primordial VSMCs are versatile cells; they must regulate (arrows). JB3 is expressed in the ECM surrounding many cell types at this developmental stage, particularly in the region surrounding expression of both cytoplasmic and extracellular proteins during the initial stages of vessel wall development. In order to investigate the notochord (x) and dorsal aspect of the aortae (arrowheads). (d) The 9D6 antigen, a putative FN variant, is preferentially expressed the role of two recently discovered ECM proteins, fibulin-1 and the JB3 antigen, in vascular development, we compared the expression in the ECM surrounding the aortae. It is present in the ECM on both the dorsal and ventral surfaces of the fusing aortae. However, of these proteins with SMaA and a variant of FN. cell fate is a two-step process, involving specification and determination phases. A cell or tissue is ''specified'' when it is capable of differentiating autonomously when placed in a neutral environment, such as in a petri dish. A cell or tissue is ''determined'' when it is capable of differentiating autonomously when placed in another region of the embryo. As these terms are experimentally defined, we cannot state definitively where expression of the 1E12 antigen lies along the VSMC commitment pathway. In addition, it is unclear whether these terms can be strictly applied to the vascular smooth muscle cell, given the extensive evidence of the plasticity of the SMC phenotype and its dependence on complex environmental cues. From the data presented in this study, however, we hypothesize that the onset of 1E12 antigen expression designates a definable, and critical, step in commitment to the smooth muscle lineage. tantly transient SMaA expression is part of the differentiation program of both primordial cardiac and skeletal muscle cells (Ruzicka and Schwartz, 1988; Sawtell and Lessard, 1989; Sugi and Lough, 1992) . Given the fact that SMaA is
1E12: An Early Marker for Determined VSMCs?
expressed in many cell types both in vitro and in vivo, it is striking that SMaA expression is observed in discrete areas To explore the hypothesis that primordial VSMCs express novel proteins as they become committed, we have proof the embryo, including the mesoderm surrounding the descending aorta. However, as shown in Fig. 4b , it is not duced monoclonal antibodies directed against embryonic vessel wall antigens. The protocols we used for generation possible to determine if the SMaA-positive cells, which are not immediately adjacent to the endothelium and not orgaand screening of these MAbs were designed to develop a useful marker for studies of vascular development. One of nized into a distinct vascular structure, are truly committed to a VSMC fate. It would appear that the SMaA-positive these MAbs, 1E12, specifically recognizes primordial VSMCs in the early embryo. Observations based on immucells surrounding the aortic endothelium have undergone a developmental decision that distinguishes them from the nolocalization show that expression of the 1E12 antigen is not a component of either the cardiac or skeletal muscle remainder of the surrounding mesoderm. There is now evidence that the SMaA gene promoter is regulated in a tissuedifferentiation program. To the best of our knowledge, 1E12 is the only defined marker which is specific to smooth musspecific manner (Shimizu et al., 1995) . However, we cannot establish whether all of the SMaA-positive cells in the recle cells at these early critical stages of vessel wall development (see Fig. 1 in the review by , for a listing gion of the aorta are expressing SMaA in a smooth musclespecific manner. It is not clear from our studies whether of the onset of expression of SMC differentiation markers). Myosin light chain kinase (MLCK) expression also has been these SMaA-positive cells surrounding the aortic endothelium are truly a population of determined primordial suggested by Duband and co-workers (1993) to be restricted to smooth muscle cells in a 30-somite chicken embryo;
VSMCs or whether SMaA expression is a component of a mesodermal cell differentiation pathway for cells located in however, these data were not shown.
As defined by Slack (1991) , commitment to a particular particular environments, with a final result that some of these cells will continue along the path of VSMC differentiThe varied expression of the JB3 antigen is, therefore, indicative of the complex differentiation program of embryonic ation and others will not. vessel wall cells. Specific local ECM biosynthesis may be one manifestation of VSMC heterogeneity during the earliFibulin 1 and the JB3 Antigen: Potential Roles in est stages of vascular development.
Vessel Wall Development
Fibulin-1 has recently been reported to be a constituent
Does the Environment Surrounding the Descending of the core of elastic tissue microfibrils in adult human
Dorsal Aorta Contribute to the Developmental vessel walls (Roark et al., 1995) . The process of elastogen-
Patterns Described by VSMC Markers?
esis is initiated by the secretion and localization of elastin precursors (aldehyde-rich protein and soluble tropoelastin) The unique environment surrounding the dorsal aorta in early development provides several clues for defining VSMC in the aortic wall at the interface of the myocardial cuff and outflow tract in stage 21-22 avian embryos (Rosenquist et lineage. From our results it appears that mesodermal cells are not recruited to the aortic endothelium equally from all al., 1988). Elastogenesis proceeds distally from this region along the length of the aorta by stage 28. Interestingly, the directions. We have observed that an initial population of mesodermally derived cells associates with the endothealdehyde-rich protein is purported to be a microfibrillar ECM protein (Rosenquist et al., 1988) . Our data suggest that lium of the descending aorta, adjacent to the ventral surface. We believe these cells to be primordial VSMCs. As shown fibulin-1 is expressed by presumptive VSMCs located on the ventral surface of fusing aortae in stage 19 embryos (Fig. in Figs. 5a and 5b, SMaA-positive cells are present in a single layer of cells located between the endoderm and en-9). This is the first report of fibulin-1 expression in the aortic vessel wall prior to the initiation of elastogenesis. Fibulindothelium. This suggests a role for either one or both of these tissues in VSMC determination. It is possible that an 1 expression by primordial VSMCs may represent an early step in the differentiation pathway of VSMCs. The expresinductive signal is released from the ventral surface of the endothelium or from another ventral structure, such as the sion of fibulin-1 may be coordinately regulated with other early markers of VSMCs, as it appears to be expressed in the endoderm. It is equally plausible that an inhibitory signal (possibly notochordal) is present near the dorsal surface of same pattern as SMaA and the 1E12 antigen. Additionally, fibulin-1 may act as a provisional matrix (or as part of a the aortic endothelium, and all surfaces of the endothelium are equally capable of recruiting mesodermal cells in its provisional matrix) for the developing vessel wall and/or may provide a template for the subsequent expression of absence.
Based on the present data, it cannot be determined what elastin precursors in the developing vessel wall.
The JB3 antigen, a putative avian fibrillin or fibrillin-assorole the endothelium has in VSMC determination and differentiation, but results from this study are consistent with ciated ECM protein, was initially identified as a marker for endocardial cell heterogeneity (Wunsch et al., 1995) . In the a paracrine role for the endothelium. In all cases the first cells to express early VSMC markers, SMaA and 1E12, were early stages of vessel wall formation it is not expressed in a fibulin-1-like pattern, although the JB3 antigen is a constilocated immediately adjacent to the endothelium. In the cardinal veins, shown in Fig. 2a , SMaA-positive cells are tutive element of vessel wall ECM later in development (Bouchey et al., 1996; Wunsch et al., 1994) . This is not initially located on the ventromedial surface of the endothelium. The cardinal vein-associated cells face the ventral surprising given that the composition of vessel wall ECM varies with the differentiated state of the VSMC. Glukhova aortic environment where SMaA-positive cells are present. It is interesting that there are no SMaA-positive cells presand co-workers have shown that as human aortic VSMCs mature the repertoire of fibronectin splice variants and lament in the mesoderm between the two vessels. Therefore, it does not appear that the SMaA-positive cells in the mesoinin chain variants the cell secretes changes (Glukhova et al., , 1990 (Glukhova et al., , 1993 . Bouchey and co-workers (1996) obderm surrounding the descending aorta are a population of VSMC precursors that ''seed'' the forming media of nearby serve a differential expression pattern for the JB3 antigen in elastic versus muscular vessels of older staged embryos. In vessels. These observations are most compatible with the hypothesis that vascular endothelial cells induce the mesoelastic vessels, the JB3 antigen is associated with all of the VSMC layers. However, in muscular vessels, such as the dermal cells in their immediate environment. Zerwes and Risau (1987) hypothesized that endothelial cells regulate coronary arteries, JB3 expression is associated only with the adventitial layers and the intima (most likely the internal the character of the vascular wall, such that a chemotactic factor (PDGF) is secreted from the basal surface of the endoelastic lamina). The results of the present study support a differential expression pattern for the JB3 antigen during thelium, causing migration of cells to the vessel wall. Interestingly, a recent report by Shinbrot et al. (1994) demonthe initial events of vessel wall development (Fig. 10) . As reviewed by Adams and Watt (1993) , regulation of ECM strates the presence of PDGF b receptors in the primordial VSMC layers of 10.5-day embryonic mouse vessels by in composition during development can have profound effects on cell behavior. It is frequently proposed that developing situ hybridization. However, this hypothesis does not address the question of whether the cells attracted to the endoVSMCs are composed of a heterogeneous population of cells (Nanaev et al., 1991; Cook et al., 1994; Mironov et al., 1995) . thelium are already committed to the VSMC differentiation program or whether factors secreted from the endothelium cruitment and/or induction signals from the endothelial cells on the aortic surfaces closest to the notochord. would also effect VSMC determination.
Alternatively, our data cannot exclude the possibility that We cannot determine from our study whether the development of vessels other than the aorta takes place in a some VSMCs may be derived from an epithelial to mesenchymal transition on the part of endothelial cells. Immunosimilar manner. The use of experimental developmental systems outside of the context of the entire embryo may histochemical analysis of fibulin-1 in our laboratory (Spence et al., 1992) and recent in situ hybridization data from help to address this issue. Studies from Krah et al. (1994) , using quail embryoid bodies, have shown that the presence Zhang et al. (1996) suggest that this ECM molecule is associated with epithelial-mesenchymal transformations in of endoderm alone is not sufficient for SMaA expression by mesodermal cells and that the endothelium may play a role other tissues such as neural tube, somite, and heart. It is intriguing, therefore, that fibulin-1 is expressed by SMaAin either VSMC determination or differentiation. Results from Saint-Jeannet and co-workers (1992), using mesoderm positive cells near the aortic endothelium. Further studies are needed to evaluate the role of endothelial cell populainduction assays in Xenopus embryos, suggest that not all mesodermal tissue is capable of SMaA expression. Howtions in vessel wall development.
It is well documented in the literature that the endoderm ever, these studies are difficult to interpret, because the only means used to identify cells as VSMC precursors in is a potent inducer of many mesodermal tissues (Gilbert, 1988; Jacobson and Sater, 1988; Flamme, 1989; Sugi and these studies was SMaA expression. Thus, it is not clear whether these SMaA-positive cells are capable of continuLough, 1994). It is possible that an inductive event between the endoderm and the splanchnic mesodermal cells, adjaing along the differentiation program for VSMCs or whether a multistep signaling mechanism is necessary. cent to the endoderm, occurs such that some of these cells are now determined to be VSMCs. From the observation
In the final analysis it is critical to remember the versatility and synthetic nature of the primordial VSMC. The prithat cells expressing SMC markers are located in the dorsal mesentery, Duband et al. (1993) speculate that VSMC premordial VSMC must coordinately regulate a repertoire of cellular as well as extracellular matrix proteins during the cursors may arise from the splanchnic epithelium which overlies the endoderm. It is noteworthy that in the present course of its differentiation program. The VSMC developmental and maturation pattern we describe with antibody study we observed SMaA-positive cells localized in a thin layer between the endoderm and endothelium in a stage 17 markers to the 1E12 antigen, SMaA, and fibulin-1 is only a small portion of the differentiation program of the vessel embryo (Figs. 5c and 5d ) prior to the formation of a dorsal mesentery in this region of the embryo. As development wall. The pattern described here yields several important clues as to the origin of VSMCs. Our work and that of others proceeds, the endoderm is drawn into the midline to form the gut. This developmental process provides a plausible (Ruzicka and Schwartz, 1988) suggest that VSMCs differentiate from the mesoderm in local environments rich in poexplanation for observing SMaA-positive cells located at the midline in later stage embryos (Fig. 6c) . That is, SMaAtential inducing molecules. The area ventral to the aortic endothelium appears to be one of these areas. positive cells, which had been located along the length of the endoderm, would be drawn toward the axial region, ventral to the aorta, and dorsal to the newly formed digestive tube.
